Health
Romanian Pharmaceutical Market Continued Its Decline In 2016; French Sanofi Loses Top Spot
Romania’s pharmaceutical market continued its decline in 2016, posting a decrease of 6.12% between June 2015 and May 2016. However, the first half of 2016 brought a change in the ranking of...
Qualicaps Invests EUR10.4M In Expanding Bucharest-Based Plant
Qualicaps, the second largest pharmaceutical capsule producer in Europe, invested EUR10.4 million in expanding its Bucharest-based plant, which will boost its annual production by 45%, the c...
Antibiotice Iasi Sales Up 9% In January-June
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period.
Generic Drug Producers In Romania Want To Be Exempted From Paying Clawback Tax
Generic medicine producers in Romania want to be exempted from paying the clawback tax, saying this measure would ensure patients’ access to cheaper medicines.
Ropharma Brasov Merges Through Absorption With Cristina Farm, Nipam Farm And Farmacia Sedofarm
Pharmaceutical company Ropharma Brasov (RPH.RO) has merged through absorption with companies Cristina Farm, Nipam Farm and Farmacia Sedofarm.
Competition Council Looks Into Takeover Of 78 Reteta Pharmacies By Sensiblu
Romania’s Competition Council on Monday said it is looking into the takeover of 78 Reteta pharmacies from Polisano group by retail pharmacy chain Sensiblu.
Antibiotice Iasi Seeks RON30M Loan From UniCredit Bank
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) has called a shareholders' meeting for August 11 to approve the contracting of a RON30 million (EUR6.7 million) loan from a UniCredit B...
Medicover Opens EUR300,000 Clinic In Cluj-Napoca
Swedish-held private healthcare provider Medicover opened a new clinic in Cluj-Napoca Thursday, in a EUR300,000 investment.
Antibiotice Iasi Exported $3.4M Worth Of Injectable Drugs To U.S. This Year
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) in June finished the delivery of a $3.4 million order for injectable medicines to the United States.